251 related articles for article (PubMed ID: 27473538)
1. Sertoli - Leydig cell tumor with retiform areas and overgrowth of rhabdomyosarcomatous elements: case report and literature review.
Burnik Papler T; Frković Grazio S; Kobal B
J Ovarian Res; 2016 Jul; 9(1):46. PubMed ID: 27473538
[TBL] [Abstract][Full Text] [Related]
2. Pediatric ovarian Sertoli-Leydig cell tumors with heterologous rhabdomyosarcoma elements: Clinical case series and review of the literature.
Koo J; Garrington TP; Kerr K; Treece AL; Cost CR
Pediatr Blood Cancer; 2020 Oct; 67(10):e28621. PubMed ID: 32729194
[TBL] [Abstract][Full Text] [Related]
3. Ovarian Sertoli-Leydig cell tumor of intermediate grade with heterologous elements of rhabdomyosarcoma. A case report and a review of the literature.
Grove A; Vestergaard V
Ann Diagn Pathol; 2006 Oct; 10(5):288-93. PubMed ID: 16979522
[TBL] [Abstract][Full Text] [Related]
4. Sertoli-Leydig cell tumor of ovary in children: A report of two cases, including retiform variant.
Sarkar P; Sengupta M; Chatterjee U; Ghosh D
Indian J Pathol Microbiol; 2021; 64(3):559-562. PubMed ID: 34341273
[TBL] [Abstract][Full Text] [Related]
5. Results from a Monocentric Long-Term Analysis of 23 Patients with Ovarian Sertoli-Leydig Cell Tumors.
Gouy S; Arfi A; Maulard A; Pautier P; Bentivegna E; Leary A; Chargari C; Genestie C; Morice P
Oncologist; 2019 May; 24(5):702-709. PubMed ID: 30201740
[TBL] [Abstract][Full Text] [Related]
6. Recurrent Sertoli-Leydig cell tumor of ovary in 8-year-old girl.
Turkyilmaz Z; Karabulut R; Ozbakir F; Pinarli G; Arda Inan M; Oguz A; Sonmez K
Scott Med J; 2016 Feb; 61(1):56-9. PubMed ID: 27334531
[TBL] [Abstract][Full Text] [Related]
7. Mucinous adenocarcinoma as heterologous element in intermediately differentiated Sertoli-Leydig cell tumor of the ovary.
Virk R; Lu D
Pathol Res Pract; 2010 Jul; 206(7):489-92. PubMed ID: 19674851
[TBL] [Abstract][Full Text] [Related]
8. Ovarian sertoli-leydig cell tumors: A multicenter long-term clinicopathological analysis of 27 patients.
Akman L; Ertas IE; Gokcu M; Terek MC; Sanci M; Sanli UA; Zekioglu O; Ozsaran AA
J Cancer Res Ther; 2016; 12(1):290-4. PubMed ID: 27072253
[TBL] [Abstract][Full Text] [Related]
9. Retiform pattern of Sertoli-Leydig cell tumor of the ovary in a 4-year-old girl.
Kawatra V; Mandal S; Khurana N; Aggarwal SK
J Obstet Gynaecol Res; 2009 Feb; 35(1):176-9. PubMed ID: 19215568
[TBL] [Abstract][Full Text] [Related]
10. DICER1 and FOXL2 Mutation Status Correlates With Clinicopathologic Features in Ovarian Sertoli-Leydig Cell Tumors.
Karnezis AN; Wang Y; Keul J; Tessier-Cloutier B; Magrill J; Kommoss S; Senz J; Yang W; Proctor L; Schmidt D; Clement PB; Gilks CB; Huntsman DG; Kommoss F
Am J Surg Pathol; 2019 May; 43(5):628-638. PubMed ID: 30986800
[TBL] [Abstract][Full Text] [Related]
11. DICER1 hotspot mutations in ovarian Sertoli-Leydig cell tumors: a potential association with androgenic effects.
Kato N; Kusumi T; Kamataki A; Tsunoda R; Fukase M; Kurose A
Hum Pathol; 2017 Jan; 59():41-47. PubMed ID: 27664536
[TBL] [Abstract][Full Text] [Related]
12. Metastatic rhabdomyosarcomatous elements, mimicking a primary sarcoma, in the omentum, from a poorly differentiated ovarian Sertoli-Leydig cell tumor in a young girl: an unusual presentation with a literature review.
Rekhi B; Karpate A; Deodhar KK; Chinoy RF
Indian J Pathol Microbiol; 2009; 52(4):554-8. PubMed ID: 19805972
[TBL] [Abstract][Full Text] [Related]
13. Characteristics and outcomes analysis of ovarian Sertoli-Leydig cell tumors (SLCTs): analysis of 15 patients.
Wang G; Zhang R; Li C; Chen A
J Ovarian Res; 2021 Nov; 14(1):150. PubMed ID: 34736487
[TBL] [Abstract][Full Text] [Related]
14. Moderately differentiated Sertoli-Leydig cell tumor of ovary with associated mucinous carcinoma and carcinoid-A case report and review of literature.
Ravichandaran A; Lakshmanan A; Kurian A; Prasad S
Indian J Pathol Microbiol; 2021; 64(3):528-531. PubMed ID: 34341265
[TBL] [Abstract][Full Text] [Related]
15. Ovarian Sertoli-Leydig Cell Tumor With Heterologous Hepatocytes and a Hepatocellular Carcinomatous Element.
Yamamoto S; Sakai Y
Int J Gynecol Pathol; 2019 May; 38(3):247-252. PubMed ID: 29620585
[TBL] [Abstract][Full Text] [Related]
16. Sertoli-Leydig cell tumor of ovary with heterologous element: a case report.
Kataria SP; Mishra K; Dev G; Tandon R
Indian J Pathol Microbiol; 2005 Oct; 48(4):493-5. PubMed ID: 16366107
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathologic features of ovarian Sertoli-Leydig cell tumors.
Zhang HY; Zhu JE; Huang W; Zhu J
Int J Clin Exp Pathol; 2014; 7(10):6956-64. PubMed ID: 25400781
[TBL] [Abstract][Full Text] [Related]
18. DICER1 Mutations Are Consistently Present in Moderately and Poorly Differentiated Sertoli-Leydig Cell Tumors.
de Kock L; Terzic T; McCluggage WG; Stewart CJR; Shaw P; Foulkes WD; Clarke BA
Am J Surg Pathol; 2017 Sep; 41(9):1178-1187. PubMed ID: 28654427
[TBL] [Abstract][Full Text] [Related]
19. Well-differentiated Sertoli-Leydig Cell Tumors (SLCTs) Are Not Associated With DICER1 Pathogenic Variants and Represent a Different Tumor Type to Moderately and Poorly Differentiated SLCTs.
McCluggage WG; Rivera B; Chong AS; Clarke BA; Schultz KAP; Dehner LP; Tchrakian N; Apellaniz-Ruiz M; Gilks CB; Kommoss F; Stewart CJR; Foulkes WD
Am J Surg Pathol; 2023 Apr; 47(4):490-496. PubMed ID: 36583307
[TBL] [Abstract][Full Text] [Related]
20. Ovarian Sertoli-Leydig cell tumor with retiform pattern.
Moyles K; Chan YF; Hamill J; Massey R
Pathology; 1995 Oct; 27(4):371-3. PubMed ID: 8771159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]